Now that cancer genes have been mapped and the price of genetic testing of the blood of a cancer patients is plummeting experts are excited about how this can inform more personalized CLL care. Dr. Catherine Wu, a leading Harvard researcher from the Dana-Farber Cancer Institute in Boston, sees the day when CLL patients will routinely have successive genetic tests over years to adjust precision treatment to keep up with new cancer gene mutations a patient might develop. She explains genetic testing for CLL in this interview with Patient Power's Andrew Schorr.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…